Risk Parity Explained: How Bridgewater's All Weather Strategy Broke in 2022

The pitch was never really about weather

Ray Dalio named it All Weather for a reason. The idea: build a portfolio that performs across every economic season, growth, inflation, recession, deflation, by balancing risk instead of balancing dollars. You don't need to predict which season is coming. You just need exposure that pays off in each one. That's the sales pitch, and it's a good one. Pensions bought it. Advisors bought it. Retail investors bought it through ETFs with names like RPAR and UPAR that basically packaged the Bridgewater logic into a ticker.

Here's what nobody said loudly enough. The entire mechanism depends on one assumption. Stocks and bonds have to move in different directions, most of the time. When stocks fall, bonds rally, and vice versa. That negative correlation is not a law of physics. It's a market regime that held for roughly two decades. Since 2000, the rolling correlation between stocks and bonds averaged around -0.20. That's a statistical relationship investors got comfortable calling a rule.

It isn't a rule. It's a bet. In 2022, that bet lost. The 24-month rolling correlation between stocks and bonds flipped to roughly +0.65, a level not seen in decades, a shift ETF Central traced directly to the same source that hit every risk parity fund at once. Stocks and bonds fell together for the same reason: the Federal Reserve raised rates aggressively to fight inflation, and higher rates hurt both bond prices and equity valuations at once. Risk parity funds hold leveraged bond exposure specifically to make bonds pull their weight against stock risk. When bonds stopped acting like a hedge, that leverage didn't cushion the fall. It multiplied it.

Most investors who bought "All Weather" branding never understood this fragility. They understood the marketing: an all-terrain vehicle for markets. What they owned was a highly engineered machine tuned for one specific kind of terrain, and 2022 was a different kind of terrain entirely.

How risk parity actually works, mechanically

Start with the flaw in a standard 60/40 portfolio (60% stocks, 40% bonds). Stocks are far more volatile than bonds. So even at 60% of the dollar allocation, equities typically contribute 85% to 90% of total portfolio risk. Your "diversified" portfolio is really an equity portfolio with a bond garnish.

Risk parity fixes this through volatility-weighting: sizing each asset class by its risk contribution, not its dollar allocation, so that stocks, bonds, and often commodities each contribute roughly equal shares of total portfolio risk. Because bonds are less volatile than stocks, hitting equal risk contribution means you need a much larger dollar allocation to bonds than a standard 60/40 split would ever use. Left there, a risk-balanced portfolio would have weak expected returns, because you've shifted so much capital into low-volatility, low-return bonds.

That's where leverage on the bond sleeve comes in. This means borrowing money, often through Treasury futures or interest rate swaps, to increase bond exposure beyond what your actual cash would buy, scaling the whole portfolio back up to a target return without concentrating risk back into equities. RPAR runs about 120% total target exposure, and its sister fund UPAR runs roughly 168%, or 1.4 times RPAR's leverage, according to RPAR's own quarterly fund review. Bridgewater's approach applies leverage across multiple asset sleeves, not just bonds, but the bond leg is typically the largest lever pulled.

The logic is elegant on a whiteboard. Equal risk contribution, then add leverage to hit a target volatility, then let negative stock-bond correlation smooth the ride. The 2022 stress test shows what happens when the whiteboard meets a regime change. The table below lines up the real numbers.

Look at that table closely, because it complicates a simplistic narrative. RPAR, at -28.46%, actually lost more than the S&P 500 that year. A strategy sold on being lower-risk than equities lost more than equities did. Meanwhile AQR's Multi-Asset fund lost 10.5%, roughly half of what Bridgewater's flagship lost, running a broadly similar playbook, per the same CAIA and Markov Processes analysis. Risk parity as a category failed the 2022 test. It didn't fail uniformly. That gap between AQR and Bridgewater, and between HFR's institutional benchmark and RPAR's retail-facing ETF, is the part of the story that gets flattened when people say risk parity simply didn't work in 2022. Some versions of it worked meaningfully better than others.

Case study: Bridgewater's All Weather fund, before and after

All Weather is the fund that put risk parity on the map, launched by Bridgewater in 1996 and built around Dalio's four-quadrant framework for economic environments. It weathered 2008 with a roughly 20% drawdown while equity markets fell far harder, and that performance is what made the strategy famous. For over a decade, All Weather stood as the proof that you could build something genuinely diversified across economic regimes, not just across individual stocks.

Then 2022 happened, and the fund lost approximately 22%, per CAIA and Markov Processes' analysis. That's not a marginal underperformance. That's a worse year than the fund had during a global financial crisis triggered by a banking system collapse. If your all-weather product posts its worst year during a comparatively conventional, if aggressive, rate-hiking cycle, you have to ask what the product is actually protecting against.

The fund did rebound. Through November 2023, All Weather posted a gain of roughly 4.5%, a real recovery but nowhere close to erasing the 2022 hole, and nowhere close to keeping pace with the S&P 500's strong 2023. Bridgewater still manages around $32 billion in the strategy, a large number in absolute terms but a fraction of what institutional risk parity assets looked like at their peak. According to AInvest's reporting, institutional risk parity AUM across the industry fell from roughly $160 billion at its 2021 peak to about $90 billion by the end of 2023, a decline of nearly 44% driven by both losses and redemptions. CalPERS, one of the largest pension systems in the country, voted in November 2025 to adopt what it calls a "total portfolio approach," replacing fixed asset-class targets, including its former Absolute Return Strategies program, with a single reference portfolio and an active risk budget, according to CalPERS' own announcement. That shift tells you how institutional allocators are voting with their capital after 2022.

The retail-accessible version of this story is smaller in dollar terms but shows the same pattern. Combined assets across US risk parity ETFs sit around $3.63 billion today, split between the SPDR Bridgewater All Weather ETF (ALLW) at roughly $1.53 billion, RPAR at about $515 million, and UPAR at a comparatively small $64 million. UPAR's tiny size, relative to its 168% leverage ambition, tells you the market gave the highest-leverage version of this trade the coldest reception of the three.

The risk that actually matters: correlation regime change and manager dispersion

Two distinct risks sit inside every risk parity allocation, and investors conflate them constantly. Separate them.

The first is correlation regime risk. Risk parity's math assumes stocks and bonds diversify each other. That assumption held with a rolling 24-month correlation averaging around -0.20 since 2000. In 2022, that correlation flipped to roughly +0.65. When correlation flips positive at the same time you're running leverage on the bond sleeve specifically to offset equity risk, the leverage stops hedging and starts compounding the loss. This isn't a bug in any one firm's implementation. It's a structural feature of the strategy itself. Any risk parity fund, run by anyone, carries this same regime risk, because the entire architecture sits on top of a historical correlation pattern rather than a guaranteed one.

The second risk is manager dispersion, and this one is about implementation, not architecture. AQR lost 10.5% in 2022. Bridgewater's flagship lost roughly 22%. Same broad strategy family, same adverse regime, more than double the difference in outcome. Why? Differences in leverage level, differences in which asset classes get included in the risk parity sleeve (commodities and TIPS exposure helped some funds and hurt others depending on timing), differences in how frequently the portfolio rebalances, and differences in whether the manager made any discretionary overlay decisions during the year. RPAR's -28.46%, worse than the S&P 500 itself, is a data point about that specific fund's construction and leverage level, not a verdict on risk parity as a whole category.

This is the part accredited investors need to sit with. Risk parity is not one product. It's a family of implementations that can differ by 10 to 15 percentage points in the same calendar year under the same market conditions. Buying "a risk parity fund" without knowing which risk parity fund is buying a bet you haven't examined.

What to actually check before you allocate

If you're an accredited investor evaluating a risk parity allocation today, skip the brand name and ask about mechanics. Four questions, specifically.

First: what's the leverage level, and on what asset class? A fund running 120% leverage, like RPAR, behaves very differently from one running 168%, like UPAR, in a rate shock. Ask for the number, not a description like "modest leverage."

Second: what correlation assumption is baked into the risk model, and how often does the manager revisit it? A fund still modeling stock-bond correlation at -0.20 as its base case is modeling the world as it existed from 2000 to 2021, not the world as it existed in 2022. Ask whether the risk model has been updated since 2022, and how.

Third: how did this specific fund perform in 2022, in actual return terms, not narrative terms? Don't accept "risk parity had a hard year" as an answer. Get the number and compare it to the table above. A -10.5% year from AQR and a -28.46% year from RPAR are not the same conversation, even though both funds get filed under the same strategy label.

Fourth: what's happened to redemptions and AUM at this fund since 2022? A strategy bleeding assets, the way institutional risk parity bled from $160 billion to $90 billion, can face liquidity pressure or forced deleveraging exactly when you need the strategy to hold steady. Ask the manager directly, and verify the number independently where you can. Bridgewater, AQR, and the ETF providers all report AUM. If a firm won't share current figures, treat that reluctance as information too.

Risk parity is not dead as a concept. Volatility-weighting and leverage-to-target-volatility remain legitimate portfolio construction tools, and a lower-correlation alternative to a plain 60/40 book still has a place in a diversified allocation for the right investor. But 2022 proved the all-weather framing oversold the reliability of stock-bond correlation. Treat this strategy as one with a known failure mode. Size your allocation accordingly, and verify the specific fund's leverage and correlation assumptions before you write the check.

Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.